Krónikus limfoid leukémia (CLL): vizsgálatok itt: Franciaország
49 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleFaecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Where
- Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Nancy, Nantes, Nice, Paris, Pessac, Poitiers, Rouen, Saint-Etienne, Toulouse
- Életkor
- 18 év and over
- People
- 150
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT04935684 - 2. fázisNot yet taking people in FranciaországStudy of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Where
- Argenteuil Cedex, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Corbeil-Essonnes, Grenoble Cedex 9, Le Chesnay Cedex, Le Mans Cedex 9, Lille Cedex, Lyon, Orleans Cedex 2, Pierre-Bénite, Pontoise, Rouen Cedex, Toulouse Cedex 9, Vandoeuvre Les Nancy Cedex
- Életkor
- 80 év and over
- People
- 95
- Run by
- The Lymphoma Academic Research Organisation
See details and how to joinNCT07739459 · EU 2025-525080-32-00 - 2. fázisTaking peopleA Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a Bcell Lymphoma-2 Inhibitor (BCL-2i) (DAYBreak CLL-201)
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Nurix Therapeutics Inc.
See details and how to join2025-521088-10-00 - 2. fázisTaking peopleFILOCLL015 - GLORIFY - A phase 2 study evaluating the bispecific CD3xCD20 antibody GLOfitamab in combination with rituximab or obinutuzumab plus cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in patients with RIchter syndrome as Frontline therapY
- Where
- Amiens, Angers Cedex 9, Bayonne, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Le Chesnay Rocquencourt, Le Mans Cedex 9, Lille Cedex, Limoges, Lomme Cedex, Lyon, Montpellier Cedex 5, Mulhouse, Orleans Cedex 2, Paris, Paris Cedex 12, Pessac, Pierre Benite Cedex, Reims Cedex, Rennes Cedex 9, Rouen, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse, Tours Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 40
- Run by
- French Innovative Leukemia Organization
See details and how to join2022-501554-11-00 - 3. fázisTaking peopleA Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Where
- La Roche Sur Yon Cedex 9, Le Mans Cedex 9, Limoges, Nantes, Nice Cedex 2, Paris Cedex 13, Pierre-Bénite, Rennes, Rouen Cedex, Tours
- Életkor
- 18 év and over
- People
- 737 worldwide
- Run by
- Loxo Oncology, Inc.
See details and how to joinNCT05254743 · EU 2023-507699-38-00 - 1. fázisNot yet taking people in FranciaországDose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
- Where
- Bordeaux, Marseille, Nantes
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116 · EU 2024-516869-36-00 - 1. fázisBefejeződöttStudy Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Where
- Clermont-Ferrand, Toulouse
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2022-501876-24-00 - 2. fázisNot yet taking people in FranciaországEpcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
- Where
- Angers, Caen Cedex 9, Chambéry, Clermont-Ferrand, La Roche Sur Yon Cedex 9, Le Mans Cedex 9, Lille Cedex, Marseille, Metz Cedex 03, Mont-De-Marsan Cedex, Montpellier Cedex 5, Nantes, Nice Cedex 2, Paris, Pessac, Pierre-Bénite, Poitiers, Pontoise, Rennes Cedex 9, Saint-Priest-en-Jarez, Strasbourg Cedex, Toulouse Cedex 9, Villejuif Cedex
- Életkor
- 18 év to 79 év
- People
- 44 worldwide
- Run by
- The Lymphoma Academic Research Organisation
See details and how to joinNCT07738887 · EU 2025-520893-20-00 - 1. fázisTaking peopleA Study to Test How Safe, Effective and How the Body Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Where
- Clermont-Ferrand, Toulouse
- Életkor
- 18 év and over
- People
- 22 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2024-514152-32-00 - No phaseTaking peopleDeterminants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
- Where
- Angers, Bordeaux, Clermont-Ferrand, La Roche-sur-Yon, Lyon, Marseille, Montpellier, Nancy, Nantes, Paris, Poitiers, Rouen
- Életkor
- 18 év and over
- People
- 60
- Run by
- Nantes University Hospital
See details and how to joinNCT07099443 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Angers, Bobigny, Nantes, Pessac, Poitiers, Saint-Cloud, Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 3. fázisTaking peopleGlobal Trial in APG2575 for Patients With CLL/SLL
- Where
- Clermont-Ferrand, Le Mans Cedex 9, Lyon, Nantes, Nantes Cedex 2, Nice Cedex 2, Nimes Cedex 9, Orleans Cedex 2, Poitiers, Pontoise, Strasbourg, Tours Cedex 9
- Életkor
- 18 év to 99 év
- People
- 400 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06104566 · EU 2023-508005-24-00 - No phaseTaking peopleEvaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Életkor
- 18 év and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848 - 2. fázisNot yet taking people in FranciaországFixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).
- Where
- Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon, Bayonne, Besançon, Chambéry, Clermont-Ferrand, Corbeil-Essonnes, Epagny Metz-tessy, Grenoble, Grenoble Cedex 9, La Roche-sur-Yon, Le Mans Cedex 9, Lyon, Mont-De-Marsan Cedex, Mulhouse, Nantes, Nantes Cedex 2, Nice Cedex 2, ORLEANS, Paris, Poitiers, Reims Cedex, Rouen, Saint-Priest-en-Jarez, Strasbourg Cedex, Tours Cedex 9, Valence, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 82
- Run by
- French Innovative Leukemia Organisation
See details and how to joinNCT07624799 · EU 2025-521199-80-00 - 3. fázisFut, nem toborozA Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Where
- Amiens Cedex 1, Argenteuil Cedex, Bayonne, Chambéry, Creteil, Metz Cedex 03, Nice Cedex 2, Orleans Cedex 2, Paris, Saint-Priest-en-Jarez
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- AbbVie
See details and how to joinNCT06428019 · EU 2024-512147-23-00 - 4. fázisTaking peopleETCABio - Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Életkor
- 18 év and over
- People
- 140
- Run by
- Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 - 4. fázisTaking peopleA Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 787 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876649 - 4. fázisTaking peopleA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 279 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876662 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Creteil Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 3. fázisTaking peopleA Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction
- Where
- Amiens Cedex 1, Bayonne, Bobigny, Le Chesnay Rocquencourt, Mulhouse, Paris, Perpignan Cedex, Toulouse, Vandoeuvre Les Nancy Cedex, Villejuif
- Életkor
- 70 év and over
- People
- 262 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07082452 · EU 2025-521634-29-00 - No phaseTaking peopleDescription of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
- Where
- Reims
- Életkor
- 18 év and over
- People
- 75
- Run by
- CHU de Reims
See details and how to joinNCT06475469 - No phaseTaking peopleVenetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
- Where
- Amiens, Besançon, Bobigny, Clermont-Ferrand, Grenoble, Lille, Lyon, Montpellier, Nancy, Paris, Pessac, Reims, Toulouse
- Életkor
- 18 év and over
- People
- 50
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT05246345 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Nantes, Rouen, Tours
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394 - No phaseTaking peopleInstitut Paoli Calmettes Chronic Lymphatic Leukemia Database
- Where
- Marseille
- Életkor
- 18 év to 95 év
- People
- 4200
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT02869529